ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0077

Characteristics of Axial Spondyloarthritis in Patients with Onset Chronic Low Back Pain After Age 45

Fatma Zohra Yasmina Heddi1, Zahira Lamri2, kheireddine khelif2, Amina Benammar2 and wafa Zahdour2, 1Oran University Hospital, Rheumatology Department/ University of Oran 1, Faculty of Medicine, Oran, Oran, Algeria, 2Oran University Hospital, Rheumatology Department/ University of Oran 1, Faculty of Medicine, Oran, Algeria

Meeting: ACR Convergence 2024

Keywords: spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: SpA Including PsA – Basic Science Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: The onset of axial spondyloarthritis (axSpA), as defined by the Assessment of SpondyloArthritis International Society (ASAS) criteria is unusual after the age of 45 years. However, axSpA can start after this age with a different phenotype than early-onset forms. The aim of this study was to assess the clinical, biological, and radiological characteristics of axSpA in patients with chronic low back pain at the onset age of older than 45 years.

Methods: A single-center cross-sectional study included patients diagnosed with axSpA between 2018 and 2023. Patients were classified into two groups according to the age of onset of low back pain: late-onset ( > 45 years) and early-onset (≤ 45 years). The clinical, biological, radiological, and therapy data of the two groups were compared. 

Results: A total of 167 patients (104 males, 63 females) were included, clinical characteristics are presented in Table 1. The onset of low back pain after the age of 45 years was observed in 16 patients (9.6%), they showed a shorter duration of disease (6.2±4.9 vs 12.2±9.5 years; p=0.01), a higher prevalence of psoriasis (56.2% vs 10.6%; p< 0.0001), higher scores of BASDAI (7.1±3.5 vs 4.2±2.0 ; p=0.02), ASDAS (4.5±1.2 vs 3.4±1.0; p=0.02) and BASFI (7.9±3.5 vs 4.5±2.5; p=0.01), a lower frequency of radiographic sacroiliitis (62.5% vs 83.2%; p=0.002), a higher prevalence of fibromyalgia (12.5% vs 1.3%; p=0.04) and less use of NSAIDs (64.3% vs 91.2%; p=0.01).  

Table 1: Demographics and disease characteristics of 167 cases of axSpA

Features

Total (167)

Sex, male (%)

62.3

Age (years), mean±SD

39.2±12.8

Age at symptom onset (years), mean±SD

27.5±11.5

Disease duration (years), mean±SD

11.6±9.3

Current smoking habit (%)

19.2

Family history of spondyloarthritis (%)

10.8

Peripheral arthritis (%)

52.1

Enthesitis (%)

42.5

Psoriasis (%)

15

Uveitis (%)

19.8

Inflammatory bowel disease (%)

10

Diabetes (%)

7.2

Depression (%)

1.2

Fibromyalgia (%)

2.4

C-Reactive protein positive (%)

78.8

Sacroiliitis on X-ray and/or MRI (%)

87.3

HLA B27 positive (%)

50

BASDAI, mean±SD

4.3±2.1

BASFI, mean±SD

4.7±2.6

No significant differences were found according to sex, family history of spondyloarthritis, inflammatory markers (ESR/CRP), HLA B27 positivity, and the use of TNF inhibitors. Logistic regression analysis confirmed that late-onset low back pain was associated with a shorter duration of disease (OR=0.89, CI 95%: 0.81-0.98), fibromyalgia (OR=0.94, CI 95%: 0.01-0.72), psoriasis (OR=0.1, CI 95%: 0.03-0.28), higher BASDAI (OR=1.5, CI 95%: 1.05-2.22), ASDAS (OR=2.63, CI 95%: 1.12-6.19) and BASFI (OR=1.88, CI 95%: 1.08-3.28) and less use of NSAIDs (OR=5.7, CI 95%: 1.65-19.90).

Conclusion: Our study showed that almost 10% of the patients with axSpA had late-onset chronic low back pain. Moreover, they had a shorter duration of disease, higher frequency of psoriasis and fibromyalgia, higher disease activity, and worse functional severity. Therefore, it is essential to define and validate diagnostic criteria for individuals with onset low back pain after age 45.


Disclosures: F. Heddi: None; Z. Lamri: None; k. khelif: None; A. Benammar: None; w. Zahdour: None.

To cite this abstract in AMA style:

Heddi F, Lamri Z, khelif k, Benammar A, Zahdour w. Characteristics of Axial Spondyloarthritis in Patients with Onset Chronic Low Back Pain After Age 45 [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/characteristics-of-axial-spondyloarthritis-in-patients-with-onset-chronic-low-back-pain-after-age-45/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characteristics-of-axial-spondyloarthritis-in-patients-with-onset-chronic-low-back-pain-after-age-45/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology